ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,150 | -11.7% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $11,500 | -24.1% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $15,150 | +126150.0% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $12 | -99.9% | 5,000 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | -28.6% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $14,000 | -6.7% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $15,000 | -21.1% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $19,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |